Neurocrine Biosciences, Inc. (NBIX)
148.06
+1.04
(+0.71%)
USD |
NASDAQ |
May 07, 11:57
Neurocrine Biosciences Free Cash Flow : 831.30M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Soleno Therapeutics, Inc. | 46.66M |
| Glaukos Corp. | -35.09M |
| Edgewise Therapeutics, Inc. | -144.07M |
| Nuvalent, Inc. | -275.21M |
| Biogen, Inc. | 2.316B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 145.80M |
| Cash from Investing (Quarterly) | -506.20M |
| Cash from Financing (Quarterly) | -86.10M |
| Free Cash Flow Per Share (Quarterly) | 1.322 |
| Free Cash Flow to Equity (Quarterly) | 201.80M |
| Free Cash Flow to Firm (Quarterly) | 136.70M |
| Free Cash Flow Yield | 5.47% |